Long-term survival in a large cohort of patients with venous thrombosis: incidence and predictors

Linda E Flinterman, Astrid van Hylckama Vlieg, Suzanne C Cannegieter, Frits R Rosendaal, Linda E Flinterman, Astrid van Hylckama Vlieg, Suzanne C Cannegieter, Frits R Rosendaal

Abstract

Background: Venous thrombosis is a common disease with a high mortality rate shortly after the event. However, details on long-term mortality in these patients are lacking. The aim of this study was to determine long-term mortality in a large cohort of patients with venous thrombosis.

Methods and findings: 4,947 patients from the Multiple Environmental and Genetic Assessment study of risk factors for venous thrombosis (MEGA study) with a first nonfatal venous thrombosis or pulmonary embolism and 6,154 control individuals without venous thrombosis, aged 18 to 70 years, were followed up for 8 years. Death and causes of death were retrieved from the Dutch death registration. Standardized mortality ratios (SMRs) were calculated for patients compared with control individuals. Several subgroups were studied as well. 736 participants (601 patients and 135 controls) died over a follow-up of 54,948 person-years. The overall mortality rate was 22.7 per 1,000 person-years (95% CI 21.0-24.6) for patients and 4.7 per 1,000 person-years (95% CI 4.0-5.6) for controls. Patients with venous thrombosis had a 4.0-fold (95% CI 3.7-4.3) increased risk of death compared with controls. The risk remained increased up to 8 years after the thrombotic event, even when no additional comorbidities were present. The highest risk of death was found for patients with additional malignancies (SMR 5.5, 95% CI 5.0-6.1). Main causes of death were diseases of the circulatory system, venous thrombosis, and malignancies. Main limitation was a maximum age of 70 at time of inclusion for the first event. Therefore results can not be generalized to those in the highest age categories.

Conclusions: Patients who experienced a first venous thrombosis had an increased risk of death which lasted up to 8 years after the event, even when no comorbidities were present at time of thrombosis. Future long-term clinical follow-up could be beneficial in these patients. Please see later in the article for the Editors' Summary.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1. Kaplan-Meier survival curves for patients…
Figure 1. Kaplan-Meier survival curves for patients and controls.

References

    1. Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost. 2000;83:657–660.
    1. Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5:692–699.
    1. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet. 1999;353:1167–1173.
    1. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med. 2000;160:761–768.
    1. Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, et al. The risk of recurrent venous thromboembolism in men and women. N Engl J Med. 2004;350:2558–2563.
    1. Baglin T, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet. 2003;362:523–526.
    1. Kahn SR. The post-thrombotic syndrome: the forgotten morbidity of deep venous thrombosis. J Thromb Thrombolysis. 2006;21:41–48.
    1. Beyth RJ, Cohen AM, Landefeld CS. Long-term outcomes of deep-vein thrombosis. Arch Intern Med. 1995;155:1031–1037.
    1. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, et al. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med. 1999;159:445–453.
    1. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353:1386–1389.
    1. Laporte S, Mismetti P, Decousus H, Uresandi F, Otero R, et al. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation. 2008;117:1711–1716.
    1. Blom JW, Doggen CJM, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293:715–722.
    1. Bezemer ID, Bare LA, Doggen CJM, Arellano AR, Tong C, et al. Gene variants associated with deep vein thrombosis. JAMA. 2008;299:1306–1314.
    1. WHO. International Statistical Classificaton of Diseases and Related Health Problems. 10th version (ICD-10) Geneva: WHO; 2009.
    1. Doodsoorzakenstatistiek CBS Nederland. The Hague: Centraal Bureau voor de Statistiek; 2007.
    1. Reitter SE, Waldhoer T, Mayerhofer M, Eigenbauer E, Ay C, et al. Long-term survival of patients with a history of venous thromboembolism. Ann Hematol. 2011;90:585–594.
    1. Sørensen HT, Mellemkjær L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000;343:1846–1850.
    1. Gross CP, Galusha DH, Krumholz HM. The impact of venous thromboembolism on risk of death or hemorrhage in older cancer patients. J Gen Intern Med. 2007;22:321–326.
    1. Prandoni P. Links between arterial and venous disease. J Intern Med. 2007;262:341–350.
    1. Bova C, Marchiori A, Noto A, Rossi V, Daniele F, et al. Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism. A retrospective cohort study. Thromb Haemost. 2006;96:132–136.
    1. Franchini M, Mannucci PM. Venous and arterial thrombosis: different sides of the same coin? Eur J Intern Med. 2008;19:476–481.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere